secwatch.observer — SEC 8-K summary
======================================

Issuer:     CervoMed Inc. (CRVO)
CIK:        0001053691
Form:       8-K
Filed at:   2026-06-19T00:58:01+00:00
Accession:  0001437749-26-021208
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CervoMed prices $10M registered direct offering of 2.5M shares at $4.00/share
-----------------------------------------------------------------------------

- 2,500,000 shares at $4.00 per share for gross proceeds of $10M.
- Closing expected on or about June 22, 2026; H.C. Wainwright as placement agent.
- Net proceeds for working capital and general corporate purposes.
- 30-day lock-up on further equity issuances; 6-month ban on variable rate transactions.
- Placement agent gets 6% cash fee and 5-year warrants exercisable at $5.00/share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053691/000143774926021208/0001437749-26-021208-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053691/000143774926021208/crvo20260618_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-021208

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer